News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current METXF market cap is 0. The company's latest EPS is CAD and P/E is N/A.
| Year End August 30 2023 | 2022 | 2023 |
|---|---|---|
| CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -70k | -640k |
| Net Income | -145k | -6.52M |
| Year End August 30 2023 | 2022 | 2023 |
|---|---|---|
| CAD ($) | CAD ($) | |
| Total Assets | 102k | 672k |
| Total Liabilities | 233k | 149k |
| Total Equity | -131k | 523k |
| Year End August 30 2023 | 2022 | 2023 |
|---|---|---|
| CAD ($) | CAD ($) | |
| Operating | -136k | -303k |
| Investing | N/A | 757k |
| Financing | 140k | 116k |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 23.56M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Me Therapeutics Holdings Inc (PK) |
| Address |
177 robson street vancouver, british columbia V6C 0A3. |
| Website | https://www.metherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
